Omnicap acted as exclusive M&A advisor to the shareholders of Chrisal on the sale of a 51% stake to the listed company HeiQ

HeiQ, a listed material innovator, acquires a 51% interest in the Belgian company Chrisal. Chrisal is expert in biotechnology and produces innovative products based on probiotics technology. This probiotic technology is mainly applied to cleaning products and cosmetics, but has many other applications.

More information about this transaction can be found in the HeiQ press release.

Omnicap advised Chrisal's shareholders on the sale of the 51% stake to HeiQ.

← Terug naar overzicht